Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by purine deoxyribonucleosides.

Abstract

The effects of purine deoxyribonucleosides on bromodeoxyurdine (BrdU) mutagenesis in Syrian hamster melanoma cells were determined. Both deoxyguanosine (dG) and deoxyadenosine (dA) were found to stimulate mutagenesis without changing the amount of BrdU in DNA. In addition, the stimulation of mutagenesis by dG and dA was suppressed by the addition of deoxycytidine (dC). These results suggest that BrdU mutagenesis involves the perturbation of dC metabolism, which perturbation is enhanced by dGTP and dATP. The mutagenic activity of dG in the absence of BrdU was tested, as was that of thymidine (dT), which we had shown previously to stimulate BrdU mutageneis. With dG alone, no increase above the spontaneous mutation frequency was detected. However, at extremely high concentration, dT in the absence of BrdU was slightly mutagenic, and the mutagenesis by dT was enhanced by dG and suppressed by dC.

• Authors: E R Kaufman, R L Davidson
• Journal: Somatic cell genetics (Somatic Cell Genet) Vol. 5 Issue 5 Pg. 653-63 (Sep 1979) ISSN: 0098-0366 [Print] United States
• PMID: 531735 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Mutagens
• Purine Nucleosides
• DNA
• Bromodeoxyuridine

Topics

• Animals
• Base Sequence
• Bromodeoxyuridine (pharmacology)
• Cricetinae
• DNA (analysis)
• Dose-Response Relationship, Drug
• Melanoma (genetics)
• Mesocricetus
• Mutagens (metabolism)
• Neoplasms, Experimental (genetics)
• Purine Nucleosides (pharmacology)
• Stimulation, Chemical